Published in Proc Natl Acad Sci U S A on February 01, 1971
Specificity studies on cytotoxic thymus-derived lymphocytes reactive with influenza virus-infected cells: evidence for dual recognition of H-2 and viral hemagglutinin antigens. Proc Natl Acad Sci U S A (1977) 1.53
Evidence that cytotoxic T cells are part of the host's response to influenza pneumonia. J Exp Med (1978) 1.25
The heterogenization of tumour cells with tuberculin. II. Studies of the antigenicity of tuberculin-heterogenized murine tumour cells in syngeneic BCG positive and BCG negative mice. Immunology (1981) 1.00
DTIC xenogenized lines obtained from an L1210 clone: clonal analysis of cytotoxic T lymphocyte reactivity. Br J Cancer (1988) 0.76
Mechanisms of in vivo generation of cytotoxic activity against syngeneic tumours. I. Local differentiation of mature cytotoxic T lymphocytes in the rejection of tumours. Immunology (1985) 0.75
Minor histocompatibility antigens do not enhance BALB/c anti-SV40 TASA response. Br J Cancer (1981) 0.75
Increased cytolytic effect of immune lymphocytes in a syngeneic tumour system following simple purification procedures. Br J Cancer Suppl (1973) 0.75
Cytotoxicity of concanavalin A-activated hamster lymphocytes. Infect Immun (1973) 0.75
Cross-reactivity between haptenic muramyl di- or tripeptide derivatives and Mycobacterium bovis BCG: potential application for enhancing tumor immunity. Infect Immun (1986) 0.75
Unimpeded growth of tumour in hosts pre-immunized with tyrosyl- or dinitrophenyl-coated tumour cells. Br J Cancer (1972) 0.75
Specific immunoprophylaxis in experimental tumour-host systems. Can Med Assoc J (1980) 0.75
Serotyping for homotransplantation. 18. Refinement of microdroplet lymphocyte cytotoxicity test. Transplantation (1968) 8.51
Passive immunity in mice against C57BL leukosis E.L. 4 by means of iso-immune serum. Cancer Res (1956) 6.32
Quantitative in vitro assay of cytotoxic cellular immunity. J Natl Cancer Inst (1970) 3.12
Differential toxicity on normal and transformed cells in vitro and inhibition of tumour development in vivo by concanavalin A. Nature (1970) 1.64
Some physical and chemical properties of concanavalin A, the phytohemagglutinin of the jack bean. Biochemistry (1967) 1.54
Ability of CBA mice to produce anti-idiotypic sera to 5563 myeloma protein. Nature (1970) 1.46
Immunologic approach to cancer. Transplant Proc (1970) 1.32
Production of active immunity to malignant neoplastic tissue. Chemical coupling to an antigenic protein carrier. Cancer (1966) 0.98
Impaired nociception and pain sensation in mice lacking the capsaicin receptor. Science (2000) 15.16
In vitro antimicrobial susceptibility of anaerobic bacteria isolated from clinical specimens. Antimicrob Agents Chemother (1972) 11.05
Immunologic and therapeutic evaluation of a synthetic peptide vaccine for the treatment of patients with metastatic melanoma. Nat Med (1998) 11.03
Evaluation of accuracy of multitest micromethod system for identification of Enterobacteriaceae. Appl Microbiol (1971) 10.28
Detection of human papilloma virus in paraffin-embedded tissue using the polymerase chain reaction. J Exp Med (1988) 9.10
Clinical utility of thoracoscopy. Chest (1992) 6.34
Practical method for isolation of anerobic bacteria in the clinical laboratory. Appl Microbiol (1971) 5.45
Identification of members of the family Enterobacteriaceae by the R-B system. Appl Microbiol (1970) 5.27
Comparison of three blood culture media for recovery of anaerobic bacteria. Appl Microbiol (1973) 5.22
Anaerobic bacteremia. Mayo Clin Proc (1972) 4.79
Microwave oven for melting laboratory media. J Clin Microbiol (1978) 4.33
Collaborative investigation of the AutoMicrobic System Enterobacteriaceae biochemical card. J Clin Microbiol (1980) 4.28
Identification of macrophage-like characteristics in a cultured murine tumor line. J Immunol (1975) 4.10
RANK is the intrinsic hematopoietic cell surface receptor that controls osteoclastogenesis and regulation of bone mass and calcium metabolism. Proc Natl Acad Sci U S A (2000) 3.95
Thymus-independent antigens: the preparation of covalent, hapten-ficoll conjugates. J Immunol (1975) 3.62
Evaluation of reagent-impregnated strips for identification of Enterobacteriaceae. Am J Med Technol (1971) 3.60
Isolation and indentification of anaerobic bacteria in the clinical laboratory. A 2-year experience. Mayo Clin Proc (1974) 3.54
Detection of cytomegalovirus DNA in peripheral blood of patients infected with human immunodeficiency virus. J Infect Dis (1988) 3.52
Cell to cell interaction in the immune response. IV. Site of action of antilymphocyte globulin. J Exp Med (1968) 3.16
Klebsiella in faecal flora of renal-transplant patients. Lancet (1970) 3.14
Quantitative in vitro assay of cytotoxic cellular immunity. J Natl Cancer Inst (1970) 3.12
Evaluation of the enterotube system for identification of members of the family Enterobacteriaceae. Appl Microbiol (1971) 3.11
Evaluation of enrichment, storage, and age of blood agar medium in relation to its ability to support growth of anaerobic bacteria. J Clin Microbiol (1976) 3.09
Structural proteins of adenovirus-associated viruses. J Virol (1971) 3.03
The derivatization of cross-linked polyacrylamide beads. Controlled introduction of functional groups for the preparation of special-purpose, biochemical adsorbents. Biochemistry (1969) 2.89
Linkage between the poly-L-lysine gene and the locus controlling the major histocompatibility antigens in strain 2 guinea pigs. Proc Natl Acad Sci U S A (1970) 2.89
Biochemical and clinical characteristics and antibiotic susceptibility of atypical Enterobacter cloacae. Appl Microbiol (1969) 2.87
Pneumocystis carinii pneumonia. Differences in lung parasite number and inflammation in patients with and without AIDS. Am Rev Respir Dis (1989) 2.86
Evaluation of the Auxotab Enteric 1 System for identification of Enterobacteriaceae. Appl Microbiol (1972) 2.85
In vitro studies of piperacilin, a new semisynthetic penicillin. Antimicrob Agents Chemother (1978) 2.82
Clinical isolation of Yersinia enterocolitica: cold temperature enrichment. J Clin Microbiol (1975) 2.76
Genetic control of immune responsiveness to a glutamic acid, alanine, tyrosine copolymer in mice. I. Linkage of responsiveness to H-2 genotype. J Immunol (1971) 2.60
API and Minitek systems in identification of clinical isolates of anaerobic gram-negative bacilli and Clostridium species. J Clin Microbiol (1979) 2.54
Coagulase-negative staphylococcal bacteremia in patients receiving immunosuppressive therapy. Arch Intern Med (1983) 2.53
Epidemiologic significance of Klebsiella pneumoniae. A 3-month study. Mayo Clin Proc (1971) 2.51
Prevalence of serotypes of Salmonella. Appl Microbiol (1969) 2.50
Clinical and bacteriologic studies of anaerobic gram-positive cocci. Mayo Clin Proc (1972) 2.48
Diverticula of the Small Bowel. Ann Surg (1934) 2.44
Heamophilus vaginalis (Corynebacterium vaginal): method for isolation and rapid biochemical identification. Health Lab Sci (1977) 2.37
Bacteroides bacteremia. Minn Med (1970) 2.36
Bacterial (suppurative) arthritis in the adult. J Bone Joint Surg Am (1970) 2.26
Evaluation of the MS-2 system for rapid identification of Enterobacteriaceae. J Clin Microbiol (1980) 2.26
Rapid identification and antimicrobial susceptibility testing of gram-negative bacilli from blood cultures by the AutoMicrobic system. J Clin Microbiol (1981) 2.24
Comparative in vitro activity of moxalactam, cefotaxime, cefoperazone, piperacillin, and aminoglycosides against gram-negative bacilli. Antimicrob Agents Chemother (1980) 2.23
Coupling of large haptens to proteins and cell surfaces: preparation of stable, optimally sensitized erythrocytes for hapten-specific, hemolytic plaque assays. Immunochemistry (1973) 2.21
Inability of mice with a defect in B-lymphocyte maturation to respond to phosphorycholine on immunogenic carriers. J Exp Med (1977) 2.18
Immunization of patients with melanoma peptide vaccines: immunologic assessment using the ELISPOT assay. Cancer J Sci Am (1998) 2.14
Markedly decreased expression of class I histocompatibility antigens, protein, and mRNA in human small-cell lung cancer. J Exp Med (1985) 2.12
Osteoprotegerin ligand modulates murine osteoclast survival in vitro and in vivo. Am J Pathol (2000) 2.12
Clinical evaluation of a lysis-centrifugation technique for the detection of septicemia. JAMA (1983) 2.12
T-cell clones from melanoma patients immunized against an anchor-modified gp100 peptide display discordant effector phenotypes. Cancer J (2001) 2.08
Analysis of DNA sequences in forty-year-old paraffin-embedded thin-tissue sections: a bridge between molecular biology and classical histology. Cancer Res (1988) 2.06
Rapid detection of cytomegalovirus in bronchoalveolar lavage specimens by a monoclonal antibody method. J Clin Microbiol (1986) 2.05
Comparison of rates of virus isolation from leukocyte populations separated from blood by conventional and Ficoll-Paque/Macrodex methods. J Clin Microbiol (1979) 2.04
Hemagglutinin-specific cytotoxic T-cell response during influenza infection. J Exp Med (1977) 1.97
Clinical evaluation of the AutoMicrobic system Yeast Biochemical Card for rapid identification of medically important yeasts. J Clin Microbiol (1981) 1.94
Histocompatibility type and immune responsiveness in random bred Hartley strain guinea pigs. J Exp Med (1970) 1.90
Gram-negative rod bacteremia: microbiologic, immunologic, and therapeutic considerations. Ann Intern Med (1977) 1.90
Brain abscess with Corynebacterium hemolyticum: report of a case. Am J Clin Pathol (1971) 1.87
Non-radioactive single strand conformation polymorphism (SSCP) using the Pharmacia 'PhastSystem'. Nucleic Acids Res (1991) 1.86
Picogram quantities of anti-Ig antibodies coupled to dextran induce B cell proliferation. J Immunol (1988) 1.84
Nosocomially acquired bacteriuria due to Proteus rettgeri and Providencia stuartii. Am J Clin Pathol (1973) 1.83
Thrombospondin 1 and type I repeat peptides of thrombospondin 1 specifically induce apoptosis of endothelial cells. Cancer Res (1997) 1.81
Serratia marcescens. Biochemical characteristics, antibiotic susceptibility patterns, and clinical significance. JAMA (1970) 1.80
In vitro susceptibility of gram-negative bacilli to gentamicin. Mayo Clin Proc (1970) 1.72
Impact of cytokine administration on the generation of antitumor reactivity in patients with metastatic melanoma receiving a peptide vaccine. J Immunol (1999) 1.71
An unusual mechanism for ligand antagonism. Science (1998) 1.69
Cell-adhesive motif in region II of malarial circumsporozoite protein. Science (1990) 1.69
An analgesia circuit activated by cannabinoids. Nature (1998) 1.68
Anti-Salmonella agglutinins in chronic active liver disease. Lancet (1971) 1.67
Expression of yeast apurinic/apyrimidinic endonuclease (APN1) protects lung epithelial cells from bleomycin toxicity. Am J Respir Cell Mol Biol (2001) 1.63
In vitro studies with netilmicin compared with amikacin, gentamicin, and tobramycin. Antimicrob Agents Chemother (1977) 1.60
Lymphocyte cytotoxicity reactions to leukemia-associated antigens in identical twins. Int J Cancer (1972) 1.55
Synthesis of large haptenic compounds having a common functional group that permits covalent linkage to proteins, cell surfaces, and adsorbents. Immunochemistry (1973) 1.54
120-kD surface glycoprotein of Pneumocystis carinii is a ligand for surfactant protein A. J Clin Invest (1992) 1.53
Specificity studies on cytotoxic thymus-derived lymphocytes reactive with influenza virus-infected cells: evidence for dual recognition of H-2 and viral hemagglutinin antigens. Proc Natl Acad Sci U S A (1977) 1.53
In vitro susceptibility of staphylococci and streptococci and influence of agar media on minimum inhibitory concentration. Mayo Clin Proc (1970) 1.53
Clinical and bacteriologic observations on the proposed species, Enterobacter agglomerans (the Herbicola-Lathyri bacteria). Mayo Clin Proc (1972) 1.52
Effects of medium and inoculum on antimicrobial susceptibility of anaerobic bacteria. Am J Clin Pathol (1974) 1.52
Site of action of antilymphocyte globulin. Lancet (1967) 1.51
Neutrophils kill pulmonary endothelial cells by a hydrogen-peroxide-dependent pathway. An in vitro model of neutrophil-mediated lung injury. Am Rev Respir Dis (1984) 1.50
Infections caused by Klebsiella ozaenae: a changing disease spectrum. J Clin Microbiol (1978) 1.50
Comparative in vitro synergistic activity of new beta-lactam antimicrobial agents and amikacin against Pseudomonas aeruginosa and Serratia marcescens. Antimicrob Agents Chemother (1981) 1.49
Detection of human papillomavirus in normal and dysplastic tissue by the polymerase chain reaction. Lab Invest (1988) 1.48
Interaction of vitronectin with Pneumocystis carinii: evidence for binding via the heparin binding domain. J Lab Clin Med (1995) 1.48
Quantitative assessment of cellular and humoral responses to skin and tumor allografts. Transplantation (1971) 1.48
Cell-to-cell interaction in the immune response. VII. Requirement for differentiation of thymus-derived cells. J Exp Med (1971) 1.46
Oxidant injury of lung parenchymal cells. J Clin Invest (1981) 1.44
Recent Trends of Some Infectious Diseases. Br Med J (1942) 1.44
Cytomegalovirus infections associated with leukocyte transfusions. Ann Intern Med (1980) 1.44
Simplified method of anaerobic incubation. Appl Microbiol (1971) 1.44
Qualitative and quantitative studies of cytotoxic immune cells. J Immunol (1971) 1.42
Functional impairment of bronchoalveolar lavage phospholipids in early Pneumocystis carinii pneumonia in rats. J Lab Clin Med (1996) 1.41
Serum levels of interleukin-2 receptor and activity of rheumatic diseases characterized by immune system activation. Arthritis Rheum (1988) 1.41
A model of myelofibrosis and osteosclerosis in mice induced by overexpressing thrombopoietin (mpl ligand): reversal of disease by bone marrow transplantation. Blood (1996) 1.40
Comparison of the Minitek test system with a conventional screening procedure for identification of Enterobacteriaceae. Health Lab Sci (1978) 1.40
Detection of human papillomavirus in formalin-fixed, invasive squamous carcinomas using the polymerase chain reaction. Am J Surg Pathol (1989) 1.40
Isolation of Plasmodium berghei (malaria) parasites by ammonium chloride lysis of infected erythrocytes. Nat New Biol (1971) 1.38
Role of fibronectin in Pneumocystis carinii attachment to cultured lung cells. J Clin Invest (1990) 1.37